Pharvaris (PHVS) Operating Leases (2021 - 2026)
Pharvaris posted quarterly Operating Leases of $623515.7 for Q1 2026, down 7.1% on a QoQ basis from $671170.0 in Q4 2025.
Pharvaris (PHVS) has 6 years of Operating Leases data on file, last reported at $623515.7 in Q1 2026.
- For the quarter ending Q1 2026, Operating Leases changed N/A year-over-year to $623515.7; the trailing twelve-month figure through Mar 2026 stood at $623515.7 (changed N/A YoY), and the FY2025 full-year result was $651432.2, down 30.13% from the prior year.
- Operating Leases for Q1 2026 stood at $623515.7, down from $671170.0 in the prior quarter.
- Across five years, Operating Leases topped out at $920562.9 in Q4 2024 and bottomed at $46872.2 in Q4 2023.
- The 5-year median for Operating Leases is $623515.7 (2026), against an average of $503317.8.
- The widest annual swing landed in 2023, when Operating Leases sank 81.58%; it then surged 1863.98% in 2024.
- A 5-year view of Operating Leases shows it stood at $254468.1 in 2022, then slumped by 81.58% to $46872.2 in 2023, then soared by 1863.98% to $920562.9 in 2024, then fell by 27.09% to $671170.0 in 2025, then fell by 7.1% to $623515.7 in 2026.
- The last three Operating Leases figures came in at $623515.7 (Q1 2026), $671170.0 (Q4 2025), and $920562.9 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Pharvaris | 267.74 Mn | -73.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 623,515.72 |
| Dec 31, 2025 | 671,170.03 |
| Dec 31, 2024 | 920,562.88 |
| Dec 31, 2023 | 46,872.25 |
| Dec 31, 2022 | 254,468.06 |
| Dec 31, 2021 | 172,455.91 |